Search

everythinglearnresearchcommunity

for

Search:↓

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Adriamycin and ifosfamide together work best for advanced soft tissue sarcomas.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Wearing a frozen glove during chemotherapy can reduce nail and skin problems but may not be comfortable for everyone.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Recognizing and managing skin side effects from chemotherapy improves patient quality of life and treatment success.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Human hair-derived particles can effectively carry and release the cancer drug Paclitaxel in a pH-sensitive manner, potentially targeting cancer cells while sparing healthy ones.

Taxol damages hair growth cells, causing hair loss.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

The new drug carriers show promise for better targeting and treating ovarian cancer.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

More research is needed to understand chemotherapy-induced hair loss and its phases.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

Annurca apple extract may protect mouse hair from damage by chemotherapy and could help treat hair loss without promoting cancer growth.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Extending androgen suppression before radiotherapy offers no extra survival benefit for intermediate-risk prostate cancer.

Cancer treatments often cause skin, nail, and hair problems.